Skip to main content

Advertisement

Log in

The effectiveness of mouthwashes in alleviating radiation-induced oral mucositis in head and neck cancer patients: a systematic review

  • Review Article
  • Published:
Oral Radiology Aims and scope Submit manuscript

Abstract

Objective

The aim of the study was to perform a systematic literature search and meta-analysis to reveal the most effective mouthwash for head and neck cancer patients who are experiencing radiation therapy-induced mucositis.

Methods

Using two electronic databases, a literature search and data interpretation were systematically performed as follows: (i) problem specification, (ii) devising of a literature search plan, (iii) literature search and retrieval of publications, and (iv) meta-analysis and data interpretation. The main problem was specified as follows: what mouthwash is effective in alleviating oral mucositis for head and neck cancer patients who are undergoing radiotherapy?

Results

The literature search yielded 354 titles and abstracts. After reviewing the extracted literature, 25 publications met the inclusion criteria for this study and 17 of 25 were eventually evaluated in the meta-analysis.

Conclusion

The results of the meta-analysis indicated that the use of a mouthwash that includes anti-inflammatory properties contributes the most to alleviating oral mucositis in patients who are undergoing radiotherapy to treat head and neck cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545–602.

    Article  Google Scholar 

  2. Japan Society for Head and Neck Cancer, Cancer Registry Committee. Report of head and neck cancer registry of Japan clinical statistics of registered patients. 2015. http://www.jshnc.umin.ne.jp/pdf/2015syourei_houkoku_1027.pdf. Accessed 3 Aug 2018.

  3. Maria OM, Eliopoulos N, Muanza T. Radiation-induced oral mucositis. Front Oncol. 2017;7:89. https://doi.org/10.3389/fonc.2017.00089.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Nicolatou-Galitis O, Dardoufas K, Markoulatos P, Sotiropoulou-Lontou A, Kyprianou K, Kolitsi G. Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash. J Oral Pathol Med. 2001;30:471–80.

    Article  PubMed  Google Scholar 

  5. Fowler JF, Lindstrom ML. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys. 1992;23:457–67.

    Article  PubMed  Google Scholar 

  6. McCloskey SA, Jaqqemauth W, Riqual NR, Hicks WL Jr, Popat SR, Sullivan TL Jr, et al. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck. Am J Clin Oncol. 2009;32:587–91.

    Article  PubMed  Google Scholar 

  7. Patel UA, Patadia MO, Holloway N, Rosen F. Poor radiotherapy compliance predicts persistent regional disease in advanced head/neck cancer. Laryngoscope. 2009;119:528–33.

    Article  PubMed  Google Scholar 

  8. Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head and neck malignancies. Int J Radiat Oncol Biol Phys. 2007;68:1110–20.

    Article  PubMed  Google Scholar 

  9. Lalla RV, Ashbury FD. The MASCC/ISOO mucositis guidelines: dissemination and clinical impact. Support Care Cancer. 2013;21:3161–3.

    Article  PubMed  Google Scholar 

  10. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336–41.

    Article  Google Scholar 

  11. Centre for Reviews and Dissemination. University of York. https://www.york.ac.uk/media/crd/Systematic_Reviews.pdf. Accessed 11 Nov 2014.

  12. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–6.

    Article  Google Scholar 

  13. The Cochrane Collaboration. Cochrane methods: Bias. https://methods.cochrane.org/bias/resources/cochrane-risk-bias-tool. Accessed 31 Jul 2017.

  14. Cochrane Community. RevMan 5. http://community.cochrane.org/tools/review-production-tools/revman-5. Accessed 31 Jul 2017.

  15. Najafi S, Najafi S, Koujan SE, Manifar S, Kharazifard MJ, Kidi S, et al. Preventive effect of Glycyrrhiza glabra extract on oral mucositis in patients under head and neck radiotherapy: a randomized clinical trial. J Dent. 2017;145:267–74.

    Google Scholar 

  16. Yokota T, Ogawa T, Takahashi S, Okami K, Fujii T, Tanaka K, et al. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study. BMC Cancer. 2017;17(1):314. https://doi.org/10.1186/s12885-017-3295-4.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Rastogi M, Khurana R, Revannasiddaiah S, Jaiswal I, Nanda SS, Gupta P, et al. Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (> 50 Gy) with or without chemotherapy. Support Care Cancer. 2017;25:1439–43.

    Article  PubMed  Google Scholar 

  18. Wong KH, Kuciejewska A, Sharabiani MTA, Ng-Cheng-Hin B, Hoy S, Hurley T, et al. A randomized controlled trial of Caphosol mouthwash in management of radiation-induced mucositis in head and neck cancer. Radiother Oncol. 2017;122:207–11.

    Article  PubMed  Google Scholar 

  19. Bonfili P, Gravina GL, Marampon F, Rughetti A, Di Staso M, Dell’Orso L, et al. Oral platelet gel supernatant plus supportive medical treatment versus supportive medical treatment in the management of radiation-induced oral mucositis: a matched explorative active control trial by propensity analysis. 2017;40:336–41.

  20. Ghalayani P, Emami H, Pakravan F, Nasr Isfahani M. Comparison of triamcinolone acetonide mucoadhesive film with licorice mucoadhesive film on radiotherapy-induced oral mucositis: a randomized double-blinded clinical trial. Asia Pac J Clin Oncol. 2017;13:e48–56.

    Article  PubMed  Google Scholar 

  21. Liang G, Du W, Ke Q, Huang B, Yang J. The effects of recombinant human granulocyte colony-stimulating factor mouthwash on radiotherapy-induced oral mucositis in locally advanced nasopharyngeal carcinoma patients. Adv Clin Exp Med. 2017;26:409–13.

    Article  PubMed  Google Scholar 

  22. Diaz-Sanchez RM, Pachon-Ibanez J, Marin-Conde F, Rodriguez-Caballero A, Gutierrez-Perez JL, Torres-Lagares D. Double-blind, randomized pilot study of bioadhesive chlorhexidine gel in the prevention and treatment of mucositis induced by chemoradiotherapy of head and neck cancer. Med Oral Pathol Oral Cir Bucal. 2015;20:e378–85.

    Article  Google Scholar 

  23. Sahebjamee M, Mansourian A, Hajimiramonhammad M, Zadeh MY, Bekhradi R, Kazemian A, et al. Comparative efficacy of aloe vera and benzydamine mouthwashes on radiation-induced oral mucositis: a triple-blind, randomized, controlled clinical trial. Oral Health Prev Dent. 2015;13:309–15.

    PubMed  Google Scholar 

  24. Allison RR, Ambrad AA, Arshoun Y, Carmel RJ, Ciuba DF, Feldman E, et al. Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck. Cancer. 2014;120:1433–40.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Hawley P, Hovan A, McGahan CE, Saunders D. A randomized placebo-controlled trial of manuka honey for radiation-induced oral mucositis. Support Care Cancer. 2014;22:751–61.

    Article  PubMed  Google Scholar 

  26. Rao S, Dinkar S, Vaishnav LK, Rao P, Rai MP, Fayad R, et al. The Indian spice turmeric delays and mitigates radiation-induced oral mucositis in patients undergoing treatment for head and neck cancer: an investigational study. Integr Cancer Ther. 2014;13:201–10.

    Article  PubMed  Google Scholar 

  27. Lambrecht M, Mercier C, Geussens Y, Nuyts S. The effect of a supersaturated calcium phosphate mouth rinse on the development of oral mucositis in head and neck cancer patients treated with (chemo)radiation: a single-center, randomized, prospective study of a calcium phosphate mouth rinse + standard of care versus standard of care. Support Care Cancer. 2013;21:2663–70.

    Article  PubMed  Google Scholar 

  28. Pawar D, Neve RS, Kalgane S, Riva A, Bombardelli E, Ronchi M, et al. SAMITAL® improves chemo/radiotherapy-induced oral mucositis in patients with head and neck cancer: results of a randomized, placebo-controlled, single-blind Phase II study. Support Care Cancer. 2014;22:751–61.

    Article  Google Scholar 

  29. Nakayama M, Fujiwara M, Nakamura T, Azuma T, Matzno S, Kamikonya N, et al. Stability of polaprezinc-containing oral rinse and its clinical effectiveness against radiotherapy-induced oral mucositis. Jpn J Drug Inform. 2013;15:133–8.

    Google Scholar 

  30. Yen SH, Wang LW, Lin YH, Jen YM, Chung YL. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2012;82:1463–70.

    Article  PubMed  Google Scholar 

  31. Sharma A, Rath GK, Chaudhary SP, Thakar A, Mohanti BK, Bahadur S. Lactobacillus brevis CD2 lozenges reduce radiation and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study. Eur J Cancer. 2012;48:875–81.

    Article  PubMed  Google Scholar 

  32. Bardy J, Molassiotis A, Ryder WD, Mais K, Sykes A, Yap B, et al. A double-blind, placebo-controlled, randomised trial of active manuka honey and standard oral care for radiation-induced oral mucositis. Br J Oral Maxillofac Surg. 2012;50:221–6.

    Article  PubMed  Google Scholar 

  33. Tosaka C, Tajima H, Inoue T, Moya M, Kobayashi M, Miura K, et al. Investigation of how to prevent mucositis induced by chemoradiotherapy. Jpn J Cancer Chemother. 2011;38:1647–51 (Japanese)

    Google Scholar 

  34. Satheeshkumar PS, Chamba MS, Balan A, Sreelatha KT, Bhatathiri VN, Bose T. Effectiveness of triclosan in the management of radiation-induced oral mucositis: a randomized clinical trial. J Cancer Res Ther. 2010;6:466–72.

    Article  PubMed  Google Scholar 

  35. Maddocks-Jennings W, Wilkinson JM, Cavanagh HM, Shillington D. Evaluating the effects of the essential oils Leptospermum scoparium (manuka) and Kunzea ericoides (kanuka) on radiotherapy induced mucositis: a randomized, placebo controlled feasibility study. Eur J Oncol Nurs. 2009;13:87–93.

    Article  PubMed  Google Scholar 

  36. Madan PD, Sequeira PS, Shenoy K, Shetty J. The effect of three mouthwashes on radiation-induced oral mucositis in patients with head and neck malignancies: a randomized control trial. J Cancer Res Ther. 2008;4:3–8.

    Article  PubMed  Google Scholar 

  37. Cheng KK, Yuen JKT. A pilot study of chlorhexidine and benzydamine oral rinses for the prevention and treatment of irradiation mucositis in patients with head and neck cancer. Cancer Nurs. 2006;29:423–30.

    Article  Google Scholar 

  38. Naidu MU, Ramana GV, Ratnam SV, Sudhavani T, Naidu KJ, Roy P, et al. A randomised, double-blind, parallel, placebo-controlled study to evaluate the efficacy of MF 5232 (Mucotrol), a concentrated oral gel wafer, in the treatment of oral mucositis. Drugs R D. 2005;6:291–8.

    Article  PubMed  Google Scholar 

  39. Trotti A, Garden A, Warde P, Symonds P, Langer C, Redman R, et al. A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. Int J Radiat Oncol Biol Phys. 2004;58:674–81.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Dr. Keiji Tanimoto (Professor Emeritus, Hiroshima University) for his help.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masaru Konishi.

Ethics declarations

Conflict of interest

Masaru Konishi, Rinus Gerardus Verdonschot, Kiichi Shimabukuro, Takashi Nakamoto, Minoru Fujita, and Naoya Kakimoto declare that they have no conflict of interest.

Human rights statements

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.

Informed consent

Informed consent was obtained from all patients for being included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Konishi, M., Verdonschot, R.G., Shimabukuro, K. et al. The effectiveness of mouthwashes in alleviating radiation-induced oral mucositis in head and neck cancer patients: a systematic review. Oral Radiol 35, 207–223 (2019). https://doi.org/10.1007/s11282-018-0361-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11282-018-0361-9

Keywords

Navigation